SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-001821
Filing Date
2014-02-10
Accepted
2014-02-10 16:51:05
Documents
9
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bota20131231_10q.htm 10-Q 866882
2 EXHIBIT 31.1 ex31-1.htm EX-31 17799
3 EXHIBIT 32.1 ex32-1.htm EX-32 7468
  Complete submission text file 0001437749-14-001821.txt   5068599

Data Files

Seq Description Document Type Size
4 EXHIBIT 101.INS bota-20131231.xml EX-101.INS 810583
5 EXHIBIT 101.SCH bota-20131231.xsd EX-101.SCH 40387
6 EXHIBIT 101.CAL bota-20131231_cal.xml EX-101.CAL 23004
7 EXHIBIT 101.DEF bota-20131231_def.xml EX-101.DEF 183306
8 EXHIBIT 101.LAB bota-20131231_lab.xml EX-101.LAB 283026
9 EXHIBIT 101.PRE bota-20131231_pre.xml EX-101.PRE 188392
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 14589779
SIC: 2836 Biological Products, (No Diagnostic Substances)